AstraZeneca PLC

• AstraZeneca is listing in New York, as Big Pharma balances the huge U.S. market with China's tempting innovation - AstraZeneca announces multibillion dollar investments in China as Big Pharma is increasingly looking east for innovation.
• World leaders flock to Beijing, hedging against U.S. disruptions - Nations that avoided China in recent years are now sending their leaders to Beijing for meetings with Chinese President Xi Jinping.
• Airbus, AstraZeneca and HSBC executives join UK's Starmer on high-stakes China trip - Executives from Airbus, AstraZeneca and HSBC are joining Prime Minister Keir Starmer on a rare China visit, highlighting the business focus of the trip amid strained global trade relations.
• 2026 is the year of obesity pills. Here's how they could reshape the GLP-1 market - Patients can already access the first GLP-1 obesity pill from Novo Nordisk, and a rival oral drug from Eli Lilly is slated for U.S. approval later this year.
• Nine of the largest pharma companies ink deals with Trump to lower drug prices - President Donald Trump has pushed to lower drug prices for Americans, which are on average nearly three times higher than overseas.
• This is how exposed European Big Pharma is to the U.S. - U.S. pricing has been the bigegts issue of the year for drugmakers heavily exposed to the U.S. market.